Single-cell and spatial architecture of primary liver cancer
Pei-Yun Zhou,Cheng Zhou,Wei Gan,Zheng Tang,Bao-Ye Sun,Jin-Long Huang,Gao Liu,Wei-Ren Liu,Meng-Xin Tian,Xi-Fei Jiang,Han Wang,Chen-Yang Tao,Yuan Fang,Wei-Feng Qu,Run Huang,Gui-Qi Zhu,Cheng Huang,Xiu-Tao Fu,Zhen-Bin Ding,Qiang Gao,Jian Zhou,Ying-Hong Shi,Yong Yi,Jia Fan,Shuang-Jian Qiu
DOI: https://doi.org/10.1038/s42003-023-05455-0
IF: 6.548
2023-11-22
Communications Biology
Abstract:Primary liver cancer (PLC) poses a leading threat to human health, and its treatment options are limited. Meanwhile, the investigation of homogeneity and heterogeneity among PLCs remains challenging. Here, using single-cell RNA sequencing, spatial transcriptomic and bulk multi-omics, we elaborated a molecular architecture of 3 PLC types, namely hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma (ICC) and combined hepatocellular-cholangiocarcinoma (CHC). Taking a high-resolution perspective, our observations revealed that CHC cells exhibit internally discordant phenotypes, whereas ICC and HCC exhibit distinct tumor-specific features. Specifically, ICC was found to be the primary source of cancer-associated fibroblasts, while HCC exhibited disrupted metabolism and greater individual heterogeneity of T cells. We further revealed a diversity of intermediate-state cells residing in the tumor-peritumor junctional zone, including a congregation of CPE + intermediate-state endothelial cells (ECs), which harbored the molecular characteristics of tumor-associated ECs and normal ECs. This architecture offers insights into molecular characteristics of PLC microenvironment, and hints that the tumor-peritumor junctional zone could serve as a targeted region for precise therapeutical strategies.
biology